Delivery Order SPE2DB24D3013-SPE2DB25FFHFF

Award Date 12/12/24
Potential Completion Date 12/13/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFHFF
    Delivery Order

This federal contract award, identified as SPE2DB24D3013|SPE2DB25FFHFF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,424.97, is for the delivery of Synthroid 200 MCG tablets in quantities of 1,000s. It is a Firm Fixed Price, Delivery Order contract with a completion date of December 13, 2024.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

This contract award is not designated with a set-aside requirement, indicating open competition. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the provision of essential pharmaceutical and medical supplies.

Generated 3/13/25, 9:49 AM